RAB13 is a key promoter of cellular migration and invasion, and MYOSLID upregulates RAB13 by inhibiting miR-1286 activity, thereby enhancing the metastatic potential of osteosarcoma (OS) cells. This evidence concerns the gene RAB13 and osteosarcoma.